Literature DB >> 8410553

Prophylactic activity of tetracycline against Brugia pahangi infection in jirds (Meriones unguiculatus).

S C Bosshardt1, J W McCall, S U Coleman, K L Jones, T A Petit, T R Klei.   

Abstract

The ability of oral tetracycline to inhibit the development of third-stage infective larvae (L3) of Brugia pahangi to adult worms in jirds was studied using 2 experimental protocols. Jirds treated with 1.4% tetracycline in drinking water for a period beginning 30 days before inoculation of L3 until 30 days post-inoculation (DPI) had 97% reduction in adult worm recovery compared to untreated controls. Jirds that received 1.2% tetracycline in drinking water beginning 1 day before until either 12 or 26 DPI had adult worm recoveries of 11% and < 1%, respectively. Untreated jirds and those given tetracycline beginning at or later than 13 DPI had similar adult worm recovery (27-29%). Prepatent periods were prolonged, and circulating microfilariae were reduced in jirds given tetracycline from 27 to 54 DPI compared to controls. These data indicate that tetracycline administered to jirds in drinking water inhibits B. pahangi development from L3 to adult worms and suggest that this effect occurs during early larval development. Tetracycline administered to infected jirds prior to and continuing through the onset of patency can also affect development of microfilaremia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410553

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  24 in total

1.  Phylogeny of Wolbachia in filarial nematodes.

Authors:  C Bandi; T J Anderson; C Genchi; M L Blaxter
Journal:  Proc Biol Sci       Date:  1998-12-22       Impact factor: 5.349

2.  The Wolbachia Symbiont: Here, There and Everywhere.

Authors:  Emilie Lefoulon; Jeremy M Foster; Alex Truchon; C K S Carlow; Barton E Slatko
Journal:  Results Probl Cell Differ       Date:  2020

Review 3.  From "the Worm" to "the Worms" and Back Again: The Evolutionary Developmental Biology of Nematodes.

Authors:  Eric S Haag; David H A Fitch; Marie Delattre
Journal:  Genetics       Date:  2018-10       Impact factor: 4.562

4.  Effects of gamma radiation on Brugia malayi infective larvae and their intracellular Wolbachia bacteria.

Authors:  R Rao; H Moussa; R P Vanderwaal; E Sampson; L J Atkinson; G J Weil
Journal:  Parasitol Res       Date:  2005-07-05       Impact factor: 2.289

5.  Relationship between Psoroptes cuniculi and the internal bacterium Serratia marcescens.

Authors:  Stefania Perrucci; Giacomo Rossi; Gianluca Fichi; Dermot J O'Brien
Journal:  Exp Appl Acarol       Date:  2005       Impact factor: 2.132

6.  Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR.

Authors:  Florence Fenollar; Max Maurin; Didier Raoult
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  Characterization of antibody responses to Wolbachia surface protein in humans with lymphatic filariasis.

Authors:  George A Punkosdy; David G Addiss; Patrick J Lammie
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility.

Authors:  A Hoerauf; K Nissen-Pähle; C Schmetz; K Henkle-Dührsen; M L Blaxter; D W Büttner; M Y Gallin; K M Al-Qaoud; R Lucius; B Fleischer
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  No evidence of Wolbachia endosymbiosis with Loa loa and Mansonella perstans.

Authors:  M P Grobusch; M Kombila; I Autenrieth; H Mehlhorn; P G Kremsner
Journal:  Parasitol Res       Date:  2003-05-14       Impact factor: 2.289

10.  Removal of Wolbachia from Brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in Mongolian gerbils (Meriones unguiculatus).

Authors:  Sharon R Chirgwin; Sharon U Coleman; Kristina H Porthouse; Jena M Nowling; George A Punkosdy; Thomas R Klei
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.